USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Sisa Phamaceutical
Address:
763d Concord Ave.
Cambridge, MA 02138
Phone:
(617) 354-2800
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $123,455.00 2
SBIR Phase II $400,000.00 1

Award List:

BENZOPYRANOPYRIDINES AS NOVEL ANALGESIC AGENTS

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$73,455.00
Agency:
HHS
Principal Investigator:
Harry G. Pars Ph.d. , Principal Investigator
Abstract:
N/a

THE OBJECTIVE OF THIS PHASE I PROPOSAL IS TO CONDUCT PILOT STUDIES TOWARD DEVELOPMENT OF A RAPID, RELIABLE AND SENSITIVE IN VIVO ASSAY FOR SCREENING POTENTIAL HEPATOCARCINOGENS.

Award Year / Program / Phase:
1984 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Ellen essigmann , SENIOR TOXICOLOGIST
Abstract:
The objective of this phase i proposal is to conduct pilot studies toward development of a rapid, reliable and sensitive in vivo assay for screening potential hepatocarcinogens. the research effort is designed to provide preliminary information on the feasibility of using the choline deficient rat,… More

BENZOPYRANOPYRIDINES AS NOVEL ANALGESIC AGENTS

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$400,000.00
Agency:
HHS
Principal Investigator:
Harry G. Pars Ph.d. , Principal Investigator
Abstract:
In this project, the investigators propose to prepare and evaluate pharmacologically six nitrogen containing analogs of delta-9-tetra-hydrocannabinols including two water soluble derivatives. these compounds are designed and m modeled after the active principle of cannabis sativa b because the… More